Patient Data Reporting Featured Articles

41. COVID-19 & The Virtual Trial Rush: Front-Line Insights 5/19/2020

    The COVID-19 pandemic caught many sponsor companies and sites unprepared. Clinical trial participants were told to stay home for their own safety and to relieve the burden on site personnel. For companies that had millions invested in trials that required data from those patients, panic set in and the rush was on for new technology solutions.

42. Move Virtual Trials From Aspiration To Reality In Today's Environment 5/14/2020

    With the COVID-19 pandemic upon us, we are at a place where the business case is clear, the barriers to adoption are largely removed, and sites and participants alike have begun accepting virtual trials as not just an option but a must.

43. eConsent In Clinical Trials: Insights For Implementation During COVID-19 And Beyond 5/7/2020

    The world has changed in the wake of COVID-19. To adjust, clinical trial sponsors must adapt their protocols, and many are urgently doing so, to provide virtual tools for clinical trial use. One example of an important tool in this space is electronic consent, or eConsent.

44. Clinical Trials At Home — Implementing Telemedicine & Virtual Visits During COVID-19 4/27/2020

    There is no denying that the COVID-19 pandemic has spurred tremendous — and fast — innovation across our industry. Most importantly, the expansion of telemedicine and virtual solutions is enabling us to meet our patients’ needs while also maintaining patient safety, study integrity, and data quality.

45. How To Combine Quality Management With Risk-Based Monitoring In Clinical Trials 3/31/2020

    It is important to understand why risk-based monitoring (RBM) alone is not enough for a trial to succeed and what the industry can do to extend the use of risk-based strategies to ultimately support improved data quality and increased patient safety in clinical trials.

46. Clinical Operations In The Age Of A Pandemic 3/12/2020

    The Beat AML (BAML) Master Clinical Trial was focused on efficiency and speed of operations, not on the coronavirus outbreak or pandemics in general. Yet, the model and technologies used by BAML are applicable for biopharma sponsors who want to adapt their clinical operations to support remote monitoring and faster acquisition of data, while preparing for another outbreak or weathering the current crisis.

47. Are You Missing Out On Critical Adverse Event Information? 3/2/2020

    If you are not using a patient reported outcomes tool, you may be missing out on critical adverse event information. Learn how one clinical trial physician discovered what information was being missed, and created a tool to fix the problem. 

48. 3 Health Tech Trends Shaping The Future Of Clinical Operations 2/11/2020

    It can be overwhelming to keep up with the rapid pace of health technology advancement; in many ways, it feels like we’re just along for the ride. Let’s fast forward and take a look into three key areas of innovation that are forcing us to face and embrace a changing technological landscape in clinical research.

49. ISR Projects Growth In eTMF Market 1/22/2020

    In December 2019, ISR Reports released the 2nd edition of its eTMF Market and Service Provider Dynamics report. The 118-page report collected data from 110 respondents who worked for sponsor companies and CROs and who had direct, recent experience with eTMF software systems.

50. Shared Decision Making & Its Impact On Clinical Trial Consideration 12/3/2019

    Patient participation forms the backbone of clinical research. Surveys reveal that up to 80 percent of patients say they are “somewhat or very willing” to join a clinical trial, yet enrollment levels remain low. For example, only 8 percent of cancer patients ever enroll in a clinical trial, despite substantial resources and efforts being invested in clinical trial advertising, transportation support, and other recruitment and retention activities.